| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.74 | 0.005 | 0.74 | Dyrk kinase inhibitor | 0.182 0.109 CID_290378 | ||
| 0.734 | 0.004 | 0.734 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.628 | 0.005 | 0.628 | MAP kinase kinase 6 inhibitor | 0.542 0.011 CID_290378 | ||
| 0.584 | 0.009 | 0.584 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.456 0.057 CID_290378 | ||
| 0.583 | 0.009 | 0.583 | GABA C receptor rho-3 antagonist | 0.487 0.029 CID_290378 | ||
| 0.558 | 0.005 | 0.558 | Peroxidase inhibitor | 0.381 0.023 CID_290378 | ||
| 0.545 | 0.005 | 0.545 | Clk dual-specificity kinase inhibitor | 0.148 0.116 CID_290378 | ||
| 0.513 | 0.004 | 0.513 | Rho-associated kinase inhibitor | 0.137 0.022 CID_290378 | ||
| 0.512 | 0.006 | 0.512 | CDC-like kinase 4 inhibitor | 0.153 0.099 CID_290378 | ||
| 0.498 | 0.005 | 0.498 | CDC-like kinase 2 inhibitor | |||
| 0.49 | 0.002 | 0.49 | CYP2A6 inhibitor | 0.181 0.01 CID_290378 | ||
| 0.483 | 0.004 | 0.483 | Rho-associated kinase II inhibitor | 0.111 0.027 CID_290378 | ||
| 0.482 | 0.005 | 0.482 | Protein kinase C nu inhibitor | |||
| 0.48 | 0.005 | 0.48 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.507 | 0.032 | 0.507 | Aldehyde oxidase inhibitor | 0.284 0.071 CID_290378 | ||
| 0.482 | 0.009 | 0.482 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.502 | 0.032 | 0.502 | 5 Hydroxytryptamine release inhibitor | 0.345 0.12 CID_290378 | ||
| 0.485 | 0.015 | 0.853 | Tumour necrosis factor alpha release inhibitor | 0.853 0.004 CID_290378 | CID_290378 | |
| 0.471 | 0.005 | 0.471 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.335 0.009 CID_290378 | ||
| 0.474 | 0.008 | 0.474 | Death-associated protein kinase 3 inhibitor | |||
| 0.471 | 0.005 | 0.471 | Abl kinase inhibitor | 0.334 0.009 CID_290378 | ||
| 0.468 | 0.005 | 0.468 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.212 0.037 CID_290378 | ||
| 0.469 | 0.009 | 0.469 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.465 | 0.005 | 0.465 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.454 | 0.004 | 0.454 | Activin receptor-like kinase 4 inhibitor | |||
| 0.459 | 0.012 | 0.459 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.453 | 0.007 | 0.453 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.452 | 0.01 | 0.452 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.446 | 0.005 | 0.446 | Interleukin 1 antagonist | 0.121 0.087 CID_290378 | ||
| 0.448 | 0.008 | 0.448 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.475 | 0.038 | 0.475 | Histamine release inhibitor | 0.207 0.194 CID_290378 | ||
| 0.436 | 0.009 | 0.436 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.421 | 0.006 | 0.421 | Protein kinase (CK1) gamma inhibitor | |||
| 0.446 | 0.037 | 0.446 | 5 Hydroxytryptamine release stimulant | 0.261 0.084 CID_290378 | ||
| 0.411 | 0.006 | 0.411 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.417 | 0.019 | 0.417 | Calcium channel activator | 0.321 0.072 CID_290378 | ||
| 0.426 | 0.032 | 0.426 | Nootropic | |||
| 0.413 | 0.024 | 0.413 | Superoxide dismutase inhibitor | 0.224 0.093 CID_290378 | ||
| 0.461 | 0.077 | 0.461 | Caspase 9 stimulant | 0.309 0.185 CID_290378 | ||
| 0.378 | 0.004 | 0.378 | Protein kinase C mu inhibitor | 0.095 0.062 CID_290378 | ||
| 0.376 | 0.003 | 0.376 | MAP kinase kinase 3 inhibitor | 0.244 0.038 CID_290378 | ||
| 0.414 | 0.051 | 0.503 | Vasodilator, peripheral | 0.503 0.027 CID_290378 | CID_290378 | |
| 0.365 | 0.004 | 0.365 | MAP kinase 13 inhibitor | 0.125 0.052 CID_290378 | ||
| 0.409 | 0.051 | 0.409 | Angiogenesis inhibitor | 0.231 0.138 CID_290378 | ||
| 0.362 | 0.005 | 0.362 | CDC-like kinase 1 inhibitor | |||
| 0.358 | 0.006 | 0.358 | Interleukin 1b antagonist | 0.148 0.042 CID_290378 | ||
| 0.361 | 0.011 | 0.361 | Protein kinase (CK1) inhibitor | |||
| 0.348 | 0.005 | 0.348 | MAP kinase 12 inhibitor | 0.137 0.051 CID_290378 | ||
| 0.348 | 0.006 | 0.348 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.342 | 0.007 | 0.342 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.343 | 0.011 | 0.343 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.356 | 0.024 | 0.356 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.343 | 0.012 | 0.343 | Glycogen synthase kinase-3 inhibitor | |||
| 0.34 | 0.009 | 0.34 | Growth factor agonist | 0.156 0.129 CID_290378 | ||
| 0.363 | 0.033 | 0.363 | Tyrosine kinase inhibitor | |||
| 0.335 | 0.009 | 0.335 | MAP kinase 9 inhibitor | |||
| 0.334 | 0.009 | 0.334 | Protein kinase (CK1) delta inhibitor | |||
| 0.319 | 0.005 | 0.319 | Protein kinase A inhibitor | |||
| 0.326 | 0.015 | 0.326 | Vascular endothelial growth factor 3 antagonist | |||
| 0.315 | 0.004 | 0.315 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.165 0.048 CID_290378 | ||
| 0.323 | 0.016 | 0.323 | LIM domain kinase 1 inhibitor | 0.131 0.12 CID_290378 | ||
| 0.31 | 0.005 | 0.31 | Pim-1 kinase inhibitor | |||
| 0.405 | 0.103 | 0.405 | MAP kinase 1 inhibitor | |||
| 0.311 | 0.013 | 0.311 | Glycogen synthase kinase-3 beta inhibitor | |||
| 0.317 | 0.022 | 0.317 | TRKC antagonist | |||
| 0.299 | 0.004 | 0.299 | I kappa B kinase 1 inhibitor | 0.065 0.055 CID_290378 | ||
| 0.327 | 0.033 | 0.327 | 5 Hydroxytryptamine uptake stimulant | 0.245 0.086 CID_290378 | ||
| 0.299 | 0.005 | 0.391 | MAP kinase 14 inhibitor | 0.391 0.005 CID_290378 | CID_290378 | |
| 0.304 | 0.012 | 0.304 | Activin receptor-like kinase 2 inhibitor | 0.117 0.101 CID_290378 | ||
| 0.292 | 0.007 | 0.292 | Raf kinase inhibitor | |||
| 0.289 | 0.006 | 0.289 | 5 Hydroxytryptamine 3E antagonist | 0.258 0.013 CID_290378 | ||
| 0.295 | 0.013 | 0.345 | Nitric-oxide synthase stimulant | 0.345 0.005 CID_290378 | CID_290378 | |
| 0.298 | 0.016 | 0.298 | I kappa B kinase epsilon inhibitor | 0.144 0.126 CID_290378 | ||
| 0.345 | 0.066 | 0.345 | Cholesterol antagonist | 0.3 0.091 CID_290378 | ||
| 0.322 | 0.043 | 0.322 | Interleukin antagonist | |||
| 0.299 | 0.02 | 0.299 | Cyclin-dependent kinase inhibitor | |||
| 0.288 | 0.009 | 0.288 | Cyclin-dependent kinase 8 inhibitor | 0.179 0.052 CID_290378 | ||
| 0.285 | 0.008 | 0.285 | p38 MAP kinase inhibitor | 0.113 0.028 CID_290378 | ||
| 0.292 | 0.016 | 0.292 | Cytokine production inhibitor | 0.136 0.074 CID_290378 | ||
| 0.279 | 0.006 | 0.279 | Protein kinase C zeta inhibitor | 0.093 0.06 CID_290378 | ||
| 0.285 | 0.013 | 0.285 | Ribosomal protein S6 kinase inhibitor | |||
| 0.299 | 0.035 | 0.299 | MAP kinase kinase 2 inhibitor | |||
| 0.313 | 0.052 | 0.321 | DNA damaging | 0.321 0.05 CID_290378 | CID_290378 | |
| 0.264 | 0.005 | 0.264 | Protein kinase C delta inhibitor | |||
| 0.263 | 0.005 | 0.263 | MAP kinase kinase 4 inhibitor | 0.13 0.115 CID_290378 | ||
| 0.269 | 0.012 | 0.269 | GABA C receptor agonist | 0.185 0.024 CID_290378 | ||
| 0.263 | 0.008 | 0.263 | Nav1.6 sodium channel blocker | 0.128 0.084 CID_290378 | ||
| 0.261 | 0.01 | 0.261 | GABA C receptor rho-2 antagonist | 0.195 0.031 CID_290378 | ||
| 0.277 | 0.026 | 0.277 | Neurotrophic factor enhancer | 0.177 0.102 CID_290378 | ||
| 0.266 | 0.016 | 0.266 | Aldehyde dehydrogenase inhibitor | 0.16 0.042 CID_290378 | ||
| 0.273 | 0.024 | 0.292 | Tumour necrosis factor antagonist | 0.292 0.019 CID_290378 | CID_290378 | |
| 0.262 | 0.014 | 0.262 | Cyclin-dependent kinase 5 inhibitor | 0.238 0.016 CID_290378 | ||
| 0.304 | 0.056 | 0.331 | Insulysin inhibitor | 0.331 0.042 CID_290378 | CID_290378 | |
| 0.282 | 0.035 | 0.282 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.251 | 0.006 | 0.251 | MAP kinase 10 inhibitor | |||
| 0.25 | 0.007 | 0.25 | Raf kinase B inhibitor | |||
| 0.265 | 0.022 | 0.265 | 3C-like protease (Human coronavirus) inhibitor | 0.145 0.11 CID_290378 | ||
| 0.248 | 0.005 | 0.248 | MAP kinase 11 inhibitor | 0.237 0.006 CID_290378 | ||
| 0.283 | 0.04 | 0.283 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.246 | 0.005 | 0.246 | MAP kinase kinase 10 inhibitor | |||
| 0.265 | 0.023 | 0.265 | Glycogen synthase kinase-3 alpha inhibitor | 0.111 0.093 CID_290378 | ||
| 0.248 | 0.008 | 0.248 | Porphobilinogen synthase inhibitor | 0.139 0.023 CID_290378 | ||
| 0.246 | 0.007 | 0.246 | Protein kinase C gamma inhibitor | 0.134 0.042 CID_290378 | ||
| 0.299 | 0.061 | 0.299 | Aryl hydrocarbon receptor agonist | 0.154 0.132 CID_290378 | ||
| 0.257 | 0.023 | 0.257 | Histone acetyltransferase inhibitor | 0.185 0.092 CID_290378 | ||
| 0.249 | 0.017 | 0.249 | Vascular endothelial growth factor 1 antagonist | |||
| 0.243 | 0.011 | 0.243 | GABA receptor agonist | 0.091 0.089 CID_290378 | ||
| 0.252 | 0.022 | 0.252 | Alpha-N-acetylglucosaminidase inhibitor | 0.196 0.035 CID_290378 | ||
| 0.259 | 0.03 | 0.259 | RET inhibitor | |||
| 0.253 | 0.023 | 0.253 | Polo-like kinase-3 inhibitor | |||
| 0.285 | 0.056 | 0.285 | Ca(v)3.3 blocker | |||
| 0.273 | 0.049 | 0.273 | Tyrosine 3 hydroxylase inhibitor | 0.263 0.057 CID_290378 | ||
| 0.225 | 0.004 | 0.225 | Protein kinase C iota inhibitor | 0.111 0.016 CID_290378 | ||
| 0.228 | 0.01 | 0.228 | CF transmembrane conductance regulator agonist | 0.163 0.056 CID_290378 | ||
| 0.235 | 0.017 | 0.235 | Cystathionine beta-synthase inhibitor | 0.129 0.051 CID_290378 | ||
| 0.286 | 0.073 | 0.286 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.218 | 0.006 | 0.218 | Phenylalanine 4-hydroxylase inhibitor | 0.106 0.023 CID_290378 | ||
| 0.242 | 0.029 | 0.288 | Heat shock protein 90 alpha antagonist | 0.288 0.016 CID_290378 | CID_290378 | |
| 0.221 | 0.009 | 0.221 | Interleukin 8 antagonist | 0.13 0.05 CID_290378 | ||
| 0.217 | 0.005 | 0.217 | MAP-kinase-activated kinase inhibitor | |||
| 0.219 | 0.008 | 0.219 | GABA A receptor agonist | 0.079 0.066 CID_290378 | ||
| 0.255 | 0.046 | 0.255 | RNA-directed DNA polymerase inhibitor | 0.205 0.093 CID_290378 | ||
| 0.216 | 0.008 | 0.216 | Platelet growth factor antagonist | |||
| 0.247 | 0.039 | 0.247 | Focal adhesion kinase 2 inhibitor | |||
| 0.258 | 0.053 | 0.258 | EphB2 antagonist | |||
| 0.213 | 0.008 | 0.213 | Stem cell growth factor agonist | |||
| 0.233 | 0.03 | 0.233 | NOS3 expression enhancer | |||
| 0.263 | 0.061 | 0.263 | 5 Hydroxytryptamine 1E antagonist | 0.206 0.124 CID_290378 | ||
| 0.235 | 0.034 | 0.235 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.226 | 0.026 | 0.226 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.226 | 0.029 | 0.226 | Interleukin 6 antagonist | |||
| 0.201 | 0.005 | 0.201 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.203 | 0.008 | 0.203 | Acetylcholine nicotinic agonist | 0.1 0.038 CID_290378 | ||
| 0.199 | 0.005 | 0.199 | Acetylcholine release stimulant | 0.116 0.054 CID_290378 | ||
| 0.207 | 0.013 | 0.207 | 5 Hydroxytryptamine 3A agonist | 0.146 0.037 CID_290378 | ||
| 0.211 | 0.019 | 0.211 | MAP kinase 3 inhibitor | |||
| 0.202 | 0.012 | 0.202 | Nav1.5 sodium channel blocker | |||
| 0.193 | 0.005 | 0.193 | Transforming growth factor antagonist | 0.067 0.053 CID_290378 | ||
| 0.354 | 0.169 | 0.354 | Antiinflammatory | 0.328 0.19 CID_290378 | ||
| 0.212 | 0.029 | 0.212 | Hexokinase inhibitor | |||
| 0.205 | 0.021 | 0.205 | Ferrochelatase inhibitor | 0.124 0.051 CID_290378 | ||
| 0.261 | 0.079 | 0.261 | Transcription factor STAT inhibitor | 0.185 0.161 CID_290378 | ||
| 0.193 | 0.012 | 0.193 | Hepatocyte growth factor antagonist | |||
| 0.184 | 0.005 | 0.184 | Nicotinic alpha4beta2 receptor antagonist | 0.078 0.053 CID_290378 | ||
| 0.21 | 0.03 | 0.21 | Neurotensin receptor agonist | 0.16 0.079 CID_290378 | ||
| 0.189 | 0.01 | 0.189 | Death-associated protein kinase 1 inhibitor | |||
| 0.215 | 0.038 | 0.215 | Succinate dehydrogenase inhibitor | 0.199 0.049 CID_290378 | ||
| 0.204 | 0.028 | 0.204 | Sodium channel (voltage-gated) blocker | |||
| 0.18 | 0.005 | 0.18 | Protein kinase B alpha inhibitor | |||
| 0.177 | 0.004 | 0.177 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.188 | 0.015 | 0.188 | Photosensitizer | 0.119 0.059 CID_290378 | ||
| 0.183 | 0.011 | 0.183 | GABA C receptor rho-1 antagonist | 0.128 0.033 CID_290378 | ||
| 0.198 | 0.027 | 0.522 | Platelet activating factor antagonist | 0.522 0.005 CID_290378 | CID_290378 | |
| 0.19 | 0.02 | 0.19 | Beta amyloid protein antagonist | |||
| 0.179 | 0.01 | 0.179 | CDC-like kinase 3 inhibitor | |||
| 0.179 | 0.011 | 0.179 | Rho-associated kinase I inhibitor | 0.104 0.029 CID_290378 | ||
| 0.182 | 0.015 | 0.182 | TRPA1 agonist | 0.11 0.071 CID_290378 | ||
| 0.19 | 0.024 | 0.19 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.209 | 0.044 | 0.209 | Cytidine deaminase inhibitor | |||
| 0.174 | 0.01 | 0.174 | Aromatase inhibitor | 0.069 0.035 CID_290378 | ||
| 0.183 | 0.02 | 0.183 | Platelet activating factor alpha antagonist | |||
| 0.18 | 0.019 | 0.18 | Pregnane X receptor agonist | 0.132 0.094 CID_290378 | ||
| 0.198 | 0.037 | 0.198 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.166 | 0.006 | 0.166 | Protein kinase B beta inhibitor | 0.094 0.03 CID_290378 | ||
| 0.178 | 0.018 | 0.178 | GABA C receptor antagonist | 0.126 0.047 CID_290378 | ||
| 0.192 | 0.035 | 0.192 | Mannose-6-phosphate isomerase inhibitor | 0.135 0.079 CID_290378 | ||
| 0.223 | 0.066 | 0.571 | Platelet aggregation inhibitor | 0.571 0.006 CID_290378 | CID_290378 | |
| 0.216 | 0.06 | 0.293 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.293 0.026 CID_290378 | CID_290378 | |
| 0.165 | 0.009 | 0.165 | Alcohol oxidase inhibitor | 0.089 0.021 CID_290378 | ||
| 0.169 | 0.013 | 0.169 | Pim-3 kinase inhibitor | |||
| 0.162 | 0.007 | 0.162 | DNA gyrase inhibitor | 0.056 0.054 CID_290378 | ||
| 0.176 | 0.021 | 0.176 | MAP kinase 8 inhibitor | |||
| 0.159 | 0.005 | 0.159 | Transforming growth factor beta 3 antagonist | |||
| 0.159 | 0.004 | 0.159 | Protein kinase C theta inhibitor | 0.061 0.035 CID_290378 | ||
| 0.162 | 0.008 | 0.162 | CDC7 inhibitor | |||
| 0.159 | 0.005 | 0.159 | Protein kinase C epsilon inhibitor | |||
| 0.232 | 0.08 | 0.232 | DNA synthesis inhibitor | 0.229 0.084 CID_290378 | ||
| 0.159 | 0.009 | 0.159 | MAP3K7 inhibitor | |||
| 0.179 | 0.029 | 0.179 | Protein kinase (CK2) alpha inhibitor | |||
| 0.192 | 0.042 | 0.206 | Heat shock protein 90 antagonist | 0.206 0.035 CID_290378 | CID_290378 | |
| 0.165 | 0.016 | 0.165 | Janus tyrosine kinase 3 inhibitor | |||
| 0.166 | 0.017 | 0.166 | Acetylcholine nicotinic antagonist | |||
| 0.164 | 0.015 | 0.164 | Transcription factor STAT6 inhibitor | 0.108 0.085 CID_290378 | ||
| 0.172 | 0.024 | 0.172 | Polo-like kinase-4 inhibitor | |||
| 0.19 | 0.043 | 0.19 | Death-associated protein kinase 2 inhibitor | |||
| 0.266 | 0.119 | 0.301 | Vasodilator, coronary | 0.301 0.086 CID_290378 | CID_290378 | |
| 0.158 | 0.011 | 0.158 | Neuronal nicotinic receptor antagonist | |||
| 0.153 | 0.007 | 0.153 | Protein kinase C eta inhibitor | |||
| 0.155 | 0.01 | 0.155 | Protein kinase C alpha inhibitor | |||
| 0.238 | 0.094 | 0.238 | Gastrin inhibitor | |||
| 0.162 | 0.021 | 0.162 | Ca2+-transporting ATPase inhibitor | 0.153 0.036 CID_290378 | ||
| 0.214 | 0.074 | 0.214 | Pyruvate kinase inhibitor | 0.184 0.091 CID_290378 | ||
| 0.161 | 0.021 | 0.161 | HIV-1 integrase (Overall Integration) inhibitor | 0.093 0.062 CID_290378 | ||
| 0.167 | 0.028 | 0.167 | MAP kinase kinase kinase inhibitor | 0.14 0.04 CID_290378 | ||
| 0.155 | 0.016 | 0.155 | Glutamate (mGluR) antagonist | 0.069 0.063 CID_290378 | ||
| 0.183 | 0.046 | 0.183 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.161 | 0.023 | 0.161 | DNA repair enzyme inhibitor | 0.148 0.033 CID_290378 | ||
| 0.149 | 0.012 | 0.149 | Lanosterol 14 alpha demethylase inhibitor | 0.103 0.051 CID_290378 | ||
| 0.164 | 0.028 | 0.164 | Protein kinase (CK2) inhibitor | |||
| 0.148 | 0.012 | 0.148 | Phosphatidylinositol kinase inhibitor | |||
| 0.139 | 0.004 | 0.139 | Glutamate (mGluR7) antagonist | 0.093 0.015 CID_290378 | ||
| 0.153 | 0.018 | 0.153 | Electrolyte absorption antagonist | |||
| 0.16 | 0.026 | 0.16 | UDP-glucose 4-epimerase inhibitor | 0.15 0.029 CID_290378 | ||
| 0.151 | 0.017 | 0.151 | Glutamate receptor agonist | |||
| 0.162 | 0.028 | 0.162 | Check point kinase 2 inhibitor | |||
| 0.177 | 0.044 | 0.177 | Alkaline phosphatase inhibitor | |||
| 0.183 | 0.05 | 0.183 | Arachidonic acid antagonist | 0.147 0.091 CID_290378 | ||
| 0.172 | 0.04 | 0.172 | MAP kinase kinase inhibitor | |||
| 0.175 | 0.043 | 0.175 | Sodium channel blocker | |||
| 0.176 | 0.045 | 0.176 | Vascular endothelial growth factor antagonist | |||
| 0.135 | 0.005 | 0.135 | Fatty acid synthase inhibitor | 0.119 0.007 CID_290378 | ||
| 0.182 | 0.052 | 0.182 | Growth factor antagonist | |||
| 0.16 | 0.031 | 0.203 | Cyclin-dependent kinase 9 inhibitor | 0.203 0.022 CID_290378 | CID_290378 | |
| 0.153 | 0.025 | 0.153 | Acetylcholine agonist | |||
| 0.139 | 0.011 | 0.139 | Phosphatidylinositol 3-kinase alpha inhibitor | |||
| 0.136 | 0.008 | 0.136 | Granulocyte macrophage colony stimulating factor agonist | 0.098 0.037 CID_290378 | ||
| 0.138 | 0.011 | 0.138 | MAP kinase kinase 8 inhibitor | |||
| 0.138 | 0.011 | 0.138 | mTOR complex 2 inhibitor | 0.087 0.052 CID_290378 | ||
| 0.142 | 0.016 | 0.142 | Raf kinase C inhibitor | |||
| 0.15 | 0.024 | 0.15 | Creatine kinase inhibitor | 0.127 0.036 CID_290378 | ||
| 0.129 | 0.003 | 0.129 | Alpha 1d adrenoreceptor agonist | 0.067 0.008 CID_290378 | ||
| 0.198 | 0.073 | 0.211 | Non-steroidal antiinflammatory agent | 0.211 0.063 CID_290378 | CID_290378 | |
| 0.138 | 0.013 | 0.138 | Bromodomain-containing protein 2 inhibitor | |||
| 0.132 | 0.007 | 0.132 | Nicotinic neuronal receptor agonist | 0.067 0.03 CID_290378 | ||
| 0.169 | 0.045 | 0.169 | NADPH oxidase inhibitor | |||
| 0.134 | 0.01 | 0.134 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.075 0.023 CID_290378 | ||
| 0.128 | 0.005 | 0.128 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.098 0.015 CID_290378 | ||
| 0.129 | 0.008 | 0.129 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.173 | 0.053 | 0.173 | Lck kinase inhibitor | |||
| 0.134 | 0.015 | 0.134 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.158 | 0.038 | 0.158 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.155 | 0.036 | 0.155 | Heat shock protein 70 antagonist | |||
| 0.131 | 0.012 | 0.131 | TRPA1 antagonist | |||
| 0.123 | 0.005 | 0.123 | Nicotinamide phosphoribosyltransferase inhibitor | |||
| 0.136 | 0.018 | 0.136 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.161 | 0.044 | 0.161 | TRKA antagonist | |||
| 0.136 | 0.02 | 0.136 | I kappa B kinase inhibitor | |||
| 0.121 | 0.005 | 0.121 | Aconitate hydratase inhibitor | 0.072 0.017 CID_290378 | ||
| 0.123 | 0.007 | 0.123 | Aryl hydrocarbon receptor antagonist | |||
| 0.125 | 0.01 | 0.125 | Pim-2 kinase inhibitor | |||
| 0.151 | 0.036 | 0.151 | Falcipain 3 inhibitor | |||
| 0.135 | 0.02 | 0.135 | Histamine N-methyltransferase inhibitor | 0.077 0.071 CID_290378 | ||
| 0.124 | 0.01 | 0.124 | Acetylcholine M5 receptor agonist | 0.061 0.054 CID_290378 | ||
| 0.159 | 0.045 | 0.168 | Glutamate receptor antagonist | 0.168 0.039 CID_290378 | CID_290378 | |
| 0.121 | 0.009 | 0.121 | 5 Hydroxytryptamine 3 agonist | |||
| 0.117 | 0.006 | 0.117 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.126 | 0.015 | 0.126 | Nav1.7 sodium channel blocker | |||
| 0.165 | 0.054 | 0.165 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.136 | 0.026 | 0.136 | TIE antagonist | |||
| 0.115 | 0.005 | 0.115 | Nicotinic alpha3beta2 receptor antagonist | 0.052 0.04 CID_290378 | ||
| 0.114 | 0.005 | 0.114 | Exportin-1 inhibitor | 0.072 0.039 CID_290378 | ||
| 0.117 | 0.008 | 0.117 | Transforming growth factor beta 1 antagonist | 0.047 0.038 CID_290378 | ||
| 0.129 | 0.02 | 0.129 | mTOR complex 1 inhibitor | |||
| 0.119 | 0.01 | 0.119 | Secretase beta inhibitor | 0.081 0.035 CID_290378 | ||
| 0.115 | 0.007 | 0.115 | Nicotinic alpha7 receptor agonist | 0.053 0.039 CID_290378 | ||
| 0.13 | 0.022 | 0.13 | Protein kinase B gamma inhibitor | |||
| 0.114 | 0.007 | 0.114 | Proto-oncogene tyrosine-protein kinase Met inhibitor | |||
| 0.137 | 0.03 | 0.137 | DOPA decarboxylase inhibitor | 0.125 0.04 CID_290378 | ||
| 0.131 | 0.025 | 0.131 | Janus tyrosine kinase 2 inhibitor | |||
| 0.125 | 0.019 | 0.125 | Glutamate release inhibitor | |||
| 0.158 | 0.053 | 0.763 | Phosphodiesterase inhibitor | 0.763 0.004 CID_290378 | CID_290378 | |
| 0.137 | 0.032 | 0.137 | Adenylate kinase inhibitor | 0.119 0.044 CID_290378 | ||
| 0.156 | 0.052 | 0.156 | MAP3K9 inhibitor | |||
| 0.113 | 0.009 | 0.113 | Protein kinase C beta inhibitor | 0.063 0.062 CID_290378 | ||
| 0.172 | 0.07 | 0.172 | Src kinase inhibitor | |||
| 0.122 | 0.019 | 0.122 | Glutamate (mGluR group I) antagonist | 0.064 0.057 CID_290378 | ||
| 0.129 | 0.027 | 0.129 | TIE-2 antagonist | |||
| 0.159 | 0.058 | 0.159 | Hemostatic | |||
| 0.122 | 0.02 | 0.122 | Tyk2 inhibitor | |||
| 0.16 | 0.059 | 0.16 | Tyrosine-protein kinase receptor antagonist | |||
| 0.129 | 0.028 | 0.129 | MAP kinase kinase 1 inhibitor | |||
| 0.216 | 0.115 | 0.216 | Transcription factor STAT3 inhibitor | 0.182 0.162 CID_290378 | ||
| 0.149 | 0.049 | 0.149 | Vascular endothelial growth factor 2 antagonist | |||
| 0.117 | 0.017 | 0.165 | Benzodiazepine agonist | 0.165 0.006 CID_290378 | CID_290378 | |
| 0.14 | 0.041 | 0.14 | Granulocyte macrophage colony stimulating factor antagonist | 0.135 0.043 CID_290378 | ||
| 0.189 | 0.091 | 0.305 | Anticonvulsant | 0.305 0.039 CID_290378 | CID_290378 | |
| 0.122 | 0.023 | 0.122 | Phosphodiesterase 6D inhibitor | |||
| 0.131 | 0.034 | 0.131 | Sphingomyelinase inhibitor | |||
| 0.152 | 0.056 | 0.152 | Nav1.2 sodium channel blocker | |||
| 0.105 | 0.009 | 0.105 | Cyclin-dependent kinase 6 inhibitor | 0.06 0.041 CID_290378 | ||
| 0.114 | 0.018 | 0.114 | Amidase inhibitor | 0.111 0.019 CID_290378 | ||
| 0.107 | 0.011 | 0.107 | Phosphatidylinositol 3-kinase beta inhibitor | |||
| 0.153 | 0.057 | 0.153 | Adenylate cyclase stimulant | |||
| 0.129 | 0.034 | 0.129 | Hedgehog signaling inhibitor | |||
| 0.246 | 0.151 | 0.912 | Toll-Like receptor 7 agonist | 0.912 0.004 CID_290378 | CID_290378 | |
| 0.118 | 0.022 | 0.118 | Keratolytic | 0.09 0.038 CID_290378 | ||
| 0.098 | 0.005 | 0.098 | Glutamate (mGluR4) antagonist | 0.058 0.015 CID_290378 | ||
| 0.128 | 0.035 | 0.128 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.124 0.037 CID_290378 | ||
| 0.103 | 0.01 | 0.103 | MAP kinase kinase 9 inhibitor | |||
| 0.123 | 0.03 | 0.123 | Triose-phosphate isomerase inhibitor | 0.117 0.034 CID_290378 | ||
| 0.193 | 0.101 | 0.193 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.127 | 0.035 | 0.127 | Interleukin 2 antagonist | |||
| 0.11 | 0.019 | 0.11 | D-Ala-D-Ala ligase inhibitor | 0.097 0.034 CID_290378 | ||
| 0.159 | 0.068 | 0.159 | Interferon gamma antagonist | |||
| 0.12 | 0.029 | 0.12 | NADH dehydrogenase inhibitor | 0.09 0.057 CID_290378 | ||
| 0.107 | 0.016 | 0.107 | Tyrosine-protein kinase EMT inhibitor | |||
| 0.107 | 0.016 | 0.107 | Phosphodiesterase VI inhibitor | |||
| 0.123 | 0.033 | 0.123 | Alcohol dehydrogenase inhibitor | |||
| 0.244 | 0.154 | 0.91 | Toll-Like receptor agonist | 0.91 0.004 CID_290378 | CID_290378 | |
| 0.134 | 0.045 | 0.134 | Cyclin-dependent kinase 2 inhibitor | |||
| 0.096 | 0.007 | 0.096 | CDK5/p25 inhibitor | |||
| 0.121 | 0.033 | 0.121 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.081 0.069 CID_290378 | ||
| 0.129 | 0.041 | 0.129 | Carbonic anhydrase XV inhibitor | |||
| 0.116 | 0.028 | 0.116 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.112 | 0.025 | 0.112 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.094 0.031 CID_290378 | ||
| 0.091 | 0.004 | 0.091 | Geranyltranstransferase inhibitor | 0.047 0.026 CID_290378 | ||
| 0.097 | 0.01 | 0.097 | Glutamate (mGluR5) antagonist | |||
| 0.14 | 0.054 | 0.14 | Cathepsin H inhibitor | 0.112 0.087 CID_290378 | ||
| 0.115 | 0.029 | 0.115 | Bcr-Abl kinase inhibitor | 0.082 0.061 CID_290378 | ||
| 0.175 | 0.09 | 0.175 | Anesthetic general | |||
| 0.11 | 0.025 | 0.11 | Myeloperoxidase inhibitor | |||
| 0.134 | 0.05 | 0.14 | DNA intercalator | 0.14 0.047 CID_290378 | CID_290378 | |
| 0.117 | 0.033 | 0.117 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.138 | 0.055 | 0.138 | TRKB antagonist | |||
| 0.228 | 0.144 | 0.228 | Transcription factor NF kappa B inhibitor | |||
| 0.091 | 0.008 | 0.091 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.088 | 0.005 | 0.088 | Diamine oxidase inhibitor | |||
| 0.09 | 0.006 | 0.09 | Glutamate (mGluR group III) antagonist | 0.05 0.021 CID_290378 | ||
| 0.12 | 0.037 | 0.12 | Phosphodiesterase 7B inhibitor | |||
| 0.093 | 0.01 | 0.093 | Cyclin D1 inhibitor | |||
| 0.085 | 0.003 | 0.085 | Nicotinic alpha3beta4 receptor agonist | 0.036 0.014 CID_290378 | ||
| 0.098 | 0.015 | 0.098 | Alpha 2 adrenoreceptor agonist | |||
| 0.091 | 0.009 | 0.091 | Glutamate (mGluR5) agonist | |||
| 0.106 | 0.024 | 0.106 | Histone deacetylase SIRT1 stimulant | |||
| 0.106 | 0.024 | 0.106 | Histone deacetylase stimulant | |||
| 0.201 | 0.12 | 0.201 | Interleukin agonist | 0.159 0.158 CID_290378 | ||
| 0.115 | 0.033 | 0.115 | Polo-like kinase-1 inhibitor | 0.09 0.062 CID_290378 | ||
| 0.162 | 0.081 | 0.162 | Antipruritic | |||
| 0.107 | 0.026 | 0.107 | Check point kinase 1 inhibitor | |||
| 0.11 | 0.029 | 0.144 | Inducible nitric-oxide synthase inhibitor | 0.144 0.017 CID_290378 | CID_290378 | |
| 0.142 | 0.062 | 0.142 | Toll-Like receptor antagonist | |||
| 0.119 | 0.039 | 0.119 | Prolactin inhibitor | 0.091 0.066 CID_290378 | ||
| 0.115 | 0.035 | 0.328 | Phosphodiesterase IV inhibitor | 0.328 0.005 CID_290378 | CID_290378 | |
| 0.111 | 0.032 | 0.111 | AXL receptor tyrosine kinase inhibitor | |||
| 0.082 | 0.005 | 0.082 | Vascular adhesion protein 1 inhibitor | |||
| 0.117 | 0.04 | 0.136 | Nitric-oxide synthase inhibitor | 0.136 0.029 CID_290378 | CID_290378 | |
| 0.082 | 0.007 | 0.082 | Urate transporter 1 inhibitor | |||
| 0.085 | 0.011 | 0.085 | Glutamate (mGluR group I) agonist | |||
| 0.118 | 0.044 | 0.118 | CDK2/cyclin A inhibitor | |||
| 0.086 | 0.012 | 0.086 | Phosphodiesterase 10A inhibitor | |||
| 0.086 | 0.012 | 0.086 | Phosphodiesterase X inhibitor | |||
| 0.117 | 0.043 | 0.117 | CDK/cyclin complex inhibitor | |||
| 0.08 | 0.006 | 0.089 | Pregnane X receptor antagonist | 0.089 0.004 CID_290378 | CID_290378 | |
| 0.115 | 0.041 | 0.115 | Uric acid excretion stimulant | |||
| 0.139 | 0.066 | 0.139 | Aurora-C kinase inhibitor | |||
| 0.09 | 0.017 | 0.09 | I kappa B kinase 2 inhibitor | |||
| 0.09 | 0.017 | 0.09 | Phosphatidylinositol 3-kinase gamma inhibitor | |||
| 0.118 | 0.045 | 0.129 | Gastric antisecretory | 0.129 0.037 CID_290378 | CID_290378 | |
| 0.109 | 0.036 | 0.109 | Catalase inhibitor | 0.086 0.044 CID_290378 | ||
| 0.085 | 0.012 | 0.085 | Oleamide hydrolase inhibitor | 0.056 0.023 CID_290378 | ||
| 0.096 | 0.024 | 0.096 | Glutamate (mGluR) agonist | |||
| 0.092 | 0.02 | 0.092 | Phospholipase D inhibitor | |||
| 0.097 | 0.028 | 0.097 | Vanilloid 1 antagonist | |||
| 0.103 | 0.034 | 0.103 | Vanilloid antagonist | |||
| 0.084 | 0.015 | 0.084 | Toll-Like receptor 8 antagonist | |||
| 0.084 | 0.015 | 0.084 | Botulinum neurotoxin type A inhibitor | |||
| 0.143 | 0.074 | 0.143 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.08 | 0.012 | 0.08 | Thromboxane synthase inhibitor | 0.05 0.048 CID_290378 | ||
| 0.082 | 0.014 | 0.082 | Glucosylceramidase inhibitor | |||
| 0.091 | 0.023 | 0.091 | MAP kinase kinase 7 inhibitor | |||
| 0.105 | 0.038 | 0.105 | ALK inhibitor | |||
| 0.089 | 0.022 | 0.089 | Potassium channel Kv1.5 blocker | |||
| 0.157 | 0.09 | 0.157 | ATPase inhibitor | |||
| 0.089 | 0.022 | 0.089 | Biliverdin reductase inhibitor | 0.074 0.029 CID_290378 | ||
| 0.076 | 0.009 | 0.076 | Glutamate (mGluR1a) antagonist | |||
| 0.149 | 0.083 | 0.149 | Melanin inhibitor | |||
| 0.072 | 0.006 | 0.072 | DNA gyrase subunit B inhibitor | |||
| 0.087 | 0.021 | 0.087 | Xanthine dehydrogenase inhibitor | |||
| 0.072 | 0.006 | 0.072 | Glutamate (mGluR3) antagonist | 0.034 0.029 CID_290378 | ||
| 0.099 | 0.033 | 0.099 | Phosphodiesterase 3A inhibitor | |||
| 0.082 | 0.016 | 0.082 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.075 | 0.009 | 0.075 | TRPM8 blocker | |||
| 0.097 | 0.031 | 0.097 | Glutamate decarboxylase inhibitor | 0.069 0.057 CID_290378 | ||
| 0.088 | 0.023 | 0.088 | Phosphatidylinositol 3-kinase delta inhibitor | |||
| 0.07 | 0.005 | 0.07 | Nerve growth factor antagonist | 0.047 0.022 CID_290378 | ||
| 0.094 | 0.029 | 0.116 | CC chemokine 5 receptor agonist | 0.116 0.01 CID_290378 | CID_290378 | |
| 0.078 | 0.013 | 0.078 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.125 | 0.061 | 0.125 | Cholesterol synthesis inhibitor | |||
| 0.081 | 0.016 | 0.081 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.082 | 0.018 | 0.082 | Phosphodiesterase 1C inhibitor | |||
| 0.098 | 0.034 | 0.098 | Phosphodiesterase 11A inhibitor | |||
| 0.098 | 0.034 | 0.098 | Phosphodiesterase XI inhibitor | |||
| 0.067 | 0.003 | 0.067 | Nicotinic alpha4beta2 receptor agonist | 0.043 0.006 CID_290378 | ||
| 0.068 | 0.005 | 0.068 | Protein kinase (CK2) beta inhibitor | |||
| 0.081 | 0.017 | 0.081 | Histone deacetylase SIRT3 inhibitor | |||
| 0.114 | 0.05 | 0.114 | Xanthine oxidase inhibitor | |||
| 0.194 | 0.131 | 0.194 | Neuropeptide Y2 antagonist | |||
| 0.068 | 0.005 | 0.068 | Transforming growth factor beta 2 antagonist | |||
| 0.109 | 0.046 | 0.109 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.071 | 0.008 | 0.071 | Glutamate (mGluR group II) antagonist | |||
| 0.117 | 0.054 | 0.138 | Aminopeptidase B inhibitor | 0.138 0.043 CID_290378 | CID_290378 | |
| 0.112 | 0.05 | 0.17 | Carbonic anhydrase III inhibitor | 0.17 0.022 CID_290378 | CID_290378 | |
| 0.096 | 0.034 | 0.096 | Histidine decarboxylase inhibitor | 0.068 0.053 CID_290378 | ||
| 0.076 | 0.015 | 0.076 | Myc inhibitor | |||
| 0.178 | 0.116 | 0.178 | Antiamyloidogenic | |||
| 0.129 | 0.068 | 0.129 | Antibacterial (Helicobacter pylori) | |||
| 0.217 | 0.157 | 0.217 | Antithrombotic | 0.205 0.171 CID_290378 | ||
| 0.079 | 0.018 | 0.079 | Transcription factor RelA inhibitor | 0.069 0.031 CID_290378 | ||
| 0.129 | 0.069 | 0.129 | c-Src kinase inhibitor | |||
| 0.092 | 0.032 | 0.092 | Aminopeptidase I inhibitor | 0.066 0.059 CID_290378 | ||
| 0.095 | 0.036 | 0.095 | Fibroblast growth factor 3 antagonist | |||
| 0.133 | 0.074 | 0.133 | Toll-Like receptor 9 antagonist | 0.122 0.084 CID_290378 | ||
| 0.104 | 0.045 | 0.104 | Toll-Like receptor 3 antagonist | |||
| 0.079 | 0.021 | 0.496 | Phosphodiesterase 4C inhibitor | 0.496 0.003 CID_290378 | CID_290378 | |
| 0.085 | 0.027 | 0.085 | Orexin receptor 1 antagonist | |||
| 0.066 | 0.009 | 0.066 | Cytokine production stimulant | |||
| 0.114 | 0.057 | 0.114 | Aurora-A kinase inhibitor | |||
| 0.062 | 0.005 | 0.062 | MAP3K5 inhibitor | |||
| 0.061 | 0.005 | 0.061 | DNA topoisomerase IV inhibitor | |||
| 0.075 | 0.019 | 0.09 | AMPA receptor antagonist | 0.09 0.014 CID_290378 | CID_290378 | |
| 0.12 | 0.064 | 0.12 | Aurora-B kinase inhibitor | |||
| 0.063 | 0.007 | 0.063 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.066 | 0.011 | 0.066 | Purinergic P2X4 antagonist | |||
| 0.075 | 0.02 | 0.075 | mTOR inhibitor | |||
| 0.135 | 0.08 | 0.135 | Cell wall synthesis inhibitor | |||
| 0.09 | 0.036 | 0.09 | Phosphofructokinase-1 inhibitor | 0.072 0.046 CID_290378 | ||
| 0.137 | 0.084 | 0.137 | Thiol protease inhibitor | |||
| 0.057 | 0.004 | 0.057 | Alpha 2a adrenoreceptor agonist | |||
| 0.077 | 0.025 | 0.077 | Glutamate (mGluR1) antagonist | 0.064 0.035 CID_290378 | ||
| 0.078 | 0.025 | 0.078 | CDK4/cyclin D1 inhibitor | |||
| 0.081 | 0.028 | 0.081 | Carbamoyl phosphate synthetase inhibitor | 0.057 0.047 CID_290378 | ||
| 0.057 | 0.005 | 0.057 | ATM kinase inhibitor | |||
| 0.061 | 0.008 | 0.061 | Potassium channel Kv1.1 blocker | |||
| 0.057 | 0.005 | 0.057 | Vanilloid 3 antagonist | |||
| 0.073 | 0.021 | 0.073 | Phosphodiesterase 1A inhibitor | |||
| 0.064 | 0.012 | 0.064 | Dopamine beta hydroxylase inhibitor | |||
| 0.06 | 0.008 | 0.06 | Histamine H1 receptor agonist | 0.044 0.03 CID_290378 | ||
| 0.098 | 0.047 | 0.098 | Phosphodiesterase I inhibitor | |||
| 0.079 | 0.029 | 0.079 | Orexin receptor antagonist | |||
| 0.056 | 0.007 | 0.056 | Glutamate (mGluR2) antagonist | |||
| 0.069 | 0.02 | 0.069 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.073 | 0.024 | 0.073 | Potassium channel (Ca-activated) blocker | |||
| 0.06 | 0.01 | 0.06 | Inosine monophosphate dehydrogenase inhibitor | 0.047 0.016 CID_290378 | ||
| 0.103 | 0.054 | 0.103 | Glutamate (mGluR7) agonist | |||
| 0.061 | 0.012 | 0.061 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.07 | 0.021 | 0.07 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.073 | 0.024 | 0.073 | NMDA 2B receptor antagonist | |||
| 0.128 | 0.079 | 0.128 | CC chemokine 6 receptor antagonist | |||
| 0.056 | 0.008 | 0.056 | Calcium release-activated channel blocker | |||
| 0.17 | 0.121 | 0.17 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.077 | 0.029 | 0.077 | Glutamate (mGluR6) antagonist | 0.073 0.035 CID_290378 | ||
| 0.121 | 0.073 | 0.121 | Cholinergic antagonist | |||
| 0.055 | 0.008 | 0.055 | Heme oxygenase inhibitor | 0.042 0.033 CID_290378 | ||
| 0.114 | 0.067 | 0.114 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.075 | 0.028 | 0.075 | Carbonic anhydrase stimulant | |||
| 0.122 | 0.076 | 0.122 | Toll-Like receptor 2 antagonist | |||
| 0.065 | 0.019 | 0.065 | Topoisomerase II beta inhibitor | |||
| 0.116 | 0.07 | 0.116 | Topoisomerase II inhibitor | |||
| 0.118 | 0.072 | 0.118 | Acetylcholine antagonist | |||
| 0.119 | 0.074 | 0.12 | Sphingosine 1-phosphate receptor 4 antagonist | 0.12 0.073 CID_290378 | CID_290378 | |
| 0.082 | 0.037 | 0.082 | GABA B receptor agonist | 0.07 0.068 CID_290378 | ||
| 0.048 | 0.003 | 0.048 | Hedgehog signaling activator | 0.03 0.014 CID_290378 | ||
| 0.087 | 0.043 | 0.635 | Phosphodiesterase 4D inhibitor | 0.635 0.003 CID_290378 | CID_290378 | |
| 0.063 | 0.019 | 0.063 | Immunoglobulin Fc receptor antagonist | |||
| 0.048 | 0.004 | 0.048 | Alpha 2b adrenoreceptor agonist | |||
| 0.103 | 0.059 | 0.106 | Anabolic | 0.106 0.054 CID_290378 | CID_290378 | |
| 0.073 | 0.029 | 0.073 | Purinergic P2X1 antagonist | |||
| 0.087 | 0.044 | 0.087 | Macrophage migration inhibitory factor inhibitor | |||
| 0.084 | 0.041 | 0.084 | Glutamate dehydrogenase inhibitor | 0.071 0.055 CID_290378 | ||
| 0.058 | 0.016 | 0.245 | Benzodiazepine inverse agonist | 0.245 0.003 CID_290378 | CID_290378 | |
| 0.076 | 0.035 | 0.078 | Cyclin A2 inhibitor | 0.078 0.034 CID_290378 | CID_290378 | |
| 0.045 | 0.004 | 0.045 | Alpha 2c adrenoreceptor agonist | 0.018 0.014 CID_290378 | ||
| 0.071 | 0.03 | 0.071 | Phosphodiesterase 1B inhibitor | |||
| 0.051 | 0.01 | 0.051 | Glucagon receptor antagonist | |||
| 0.067 | 0.026 | 0.067 | Bombesin 3 receptor antagonist | |||
| 0.102 | 0.062 | 0.666 | Bronchodilator | 0.666 0.004 CID_290378 | CID_290378 | |
| 0.079 | 0.039 | 0.079 | Alpha adrenoreceptor agonist | |||
| 0.087 | 0.047 | 0.087 | Caspase 7 inhibitor | |||
| 0.047 | 0.007 | 0.047 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.055 | 0.015 | 0.055 | GABA B receptor antagonist | |||
| 0.048 | 0.008 | 0.048 | ATR kinase inhibitor | |||
| 0.082 | 0.042 | 0.082 | Polo-like kinase-2 inhibitor | |||
| 0.063 | 0.024 | 0.063 | Lysine-specific demethylase 1A inhibitor | |||
| 0.152 | 0.114 | 0.152 | Psychostimulant | |||
| 0.09 | 0.052 | 0.09 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.071 | 0.033 | 0.071 | Janus tyrosine kinase 1 inhibitor | |||
| 0.041 | 0.004 | 0.041 | Nicotinic alpha4 receptor agonist | 0.017 0.01 CID_290378 | ||
| 0.063 | 0.026 | 0.063 | 5 Hydroxytryptamine 7 agonist | |||
| 0.076 | 0.039 | 0.179 | Phosphodiesterase 4B inhibitor | 0.179 0.009 CID_290378 | CID_290378 | |
| 0.055 | 0.018 | 0.055 | Histamine H2 receptor agonist | |||
| 0.066 | 0.03 | 0.066 | CDK4/cyclin D inhibitor | |||
| 0.052 | 0.016 | 0.052 | Plasmepsin II inhibitor | |||
| 0.041 | 0.005 | 0.041 | Imidazoline I1 receptor antagonist | |||
| 0.044 | 0.008 | 0.044 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.065 | 0.029 | 0.065 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.057 | 0.021 | 0.057 | Glucose-6-phosphate isomerase inhibitor | 0.049 0.031 CID_290378 | ||
| 0.057 | 0.023 | 0.061 | Potassium channel (Inward rectifier) activator | 0.061 0.019 CID_290378 | CID_290378 | |
| 0.075 | 0.04 | 0.075 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.054 | 0.02 | 0.054 | Dihydroorotase inhibitor | |||
| 0.095 | 0.061 | 0.095 | Fibroblast growth factor 1 antagonist | |||
| 0.076 | 0.042 | 0.076 | CDK2/cyclin E2 inhibitor | |||
| 0.044 | 0.01 | 0.044 | CDK6/cyclin D3 inhibitor | |||
| 0.055 | 0.021 | 0.055 | Glutamate (mGluR group III) agonist | |||
| 0.066 | 0.033 | 0.066 | Argininosuccinate synthase inhibitor | 0.054 0.042 CID_290378 | ||
| 0.046 | 0.013 | 0.047 | CF transmembrane conductance regulator antagonist | 0.047 0.011 CID_290378 | CID_290378 | |
| 0.055 | 0.022 | 0.058 | Potassium channel (ATP-sensitive) activator | 0.058 0.018 CID_290378 | CID_290378 | |
| 0.156 | 0.124 | 0.156 | HERG channel blocker | |||
| 0.071 | 0.039 | 0.071 | Potassium channel (ATP-sensitive) blocker | |||
| 0.07 | 0.037 | 0.07 | Cyclin A inhibitor | 0.069 0.038 CID_290378 | ||
| 0.037 | 0.005 | 0.037 | Glucosylceramidase stimulant | |||
| 0.064 | 0.032 | 0.064 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.064 | 0.032 | 0.064 | Cyclin A1 inhibitor | |||
| 0.081 | 0.049 | 0.081 | Focal adhesion kinase 1 inhibitor | |||
| 0.073 | 0.041 | 0.073 | Phosphodiesterase III inhibitor | |||
| 0.075 | 0.044 | 0.075 | Syk tyrosine kinase inhibitor | |||
| 0.055 | 0.024 | 0.055 | Aldosterone antagonist | |||
| 0.091 | 0.059 | 0.11 | Potassium channel activator | 0.11 0.039 CID_290378 | CID_290378 | |
| 0.039 | 0.007 | 0.042 | MAP3K8 inhibitor | 0.042 0.006 CID_290378 | CID_290378 | |
| 0.036 | 0.006 | 0.036 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.053 | 0.022 | 0.053 | Benzodiazepine antagonist | |||
| 0.1 | 0.07 | 0.1 | Beta glucuronidase inhibitor | |||
| 0.096 | 0.066 | 0.096 | Insulin receptor antagonist | |||
| 0.05 | 0.021 | 0.05 | Guanylate cyclase inhibitor | |||
| 0.042 | 0.013 | 0.042 | 5 Hydroxytryptamine 1D agonist | |||
| 0.063 | 0.033 | 0.063 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.076 | 0.046 | 0.076 | Potassium channel (Tandem pore domain) blocker | |||
| 0.084 | 0.055 | 0.084 | Estrogen-related receptor beta agonist | |||
| 0.046 | 0.017 | 0.046 | 5 Hydroxytryptamine 2B agonist | |||
| 0.059 | 0.031 | 0.059 | GABA A receptor antagonist | 0.052 0.039 CID_290378 | ||
| 0.048 | 0.019 | 0.048 | Dopamine D5 agonist | 0.037 0.032 CID_290378 | ||
| 0.076 | 0.048 | 0.076 | Vanilloid 4 agonist | |||
| 0.075 | 0.047 | 0.075 | NMDA 2 receptor antagonist | |||
| 0.083 | 0.055 | 0.083 | T cell inhibitor | |||
| 0.042 | 0.014 | 0.042 | Ceramide glucosyltransferase inhibitor | |||
| 0.069 | 0.042 | 0.069 | Fibroblast growth factor 2 antagonist | |||
| 0.059 | 0.032 | 0.059 | Sphingosine kinase 2 inhibitor | |||
| 0.034 | 0.007 | 0.034 | Glutamate (mGluR1a) agonist | 0.02 0.018 CID_290378 | ||
| 0.055 | 0.028 | 0.055 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.041 | 0.015 | 0.041 | Free fatty acid receptor 1 antagonist | |||
| 0.035 | 0.009 | 0.035 | Myristoyl transferase inhibitor | |||
| 0.076 | 0.05 | 0.076 | Acetylcholine M4 receptor antagonist | |||
| 0.032 | 0.006 | 0.04 | Complement factor 1s inhibitor | 0.04 0.004 CID_290378 | CID_290378 | |
| 0.043 | 0.018 | 0.043 | Orexin receptor 2 antagonist | |||
| 0.059 | 0.033 | 0.059 | GABA receptor antagonist | 0.051 0.043 CID_290378 | ||
| 0.1 | 0.075 | 0.1 | Alpha 2b adrenoreceptor antagonist | |||
| 0.075 | 0.05 | 0.075 | Adenosine A3 receptor antagonist | |||
| 0.197 | 0.173 | 0.197 | Caspase 3 stimulant | |||
| 0.054 | 0.03 | 0.054 | Potassium channel (Inward rectifier) blocker | |||
| 0.04 | 0.016 | 0.04 | Glutamate (mGluR4) agonist | |||
| 0.091 | 0.067 | 0.091 | Potassium channel (Voltage-sensitive) activator | |||
| 0.056 | 0.032 | 0.056 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.068 | 0.044 | 0.068 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.053 | 0.029 | 0.053 | Squalene epoxidase inhibitor | |||
| 0.042 | 0.019 | 0.042 | Glutamate (mGluR group II) agonist | |||
| 0.046 | 0.023 | 0.056 | Angiotensin AT1 receptor antagonist | 0.056 0.01 CID_290378 | CID_290378 | |
| 0.033 | 0.01 | 0.033 | Prostaglandin H2 antagonist | |||
| 0.154 | 0.131 | 0.154 | Potassium channel blocker | |||
| 0.046 | 0.024 | 0.046 | DNA-dependent protein kinase inhibitor | |||
| 0.029 | 0.007 | 0.029 | ICAM 1 antagonist | |||
| 0.051 | 0.029 | 0.051 | Adenosine deaminase inhibitor | |||
| 0.036 | 0.014 | 0.036 | Cyclin E2 inhibitor | |||
| 0.039 | 0.018 | 0.039 | Glutamate (mGluR2) agonist | |||
| 0.038 | 0.016 | 0.038 | Melatonin receptor 1A agonist | |||
| 0.024 | 0.004 | 0.024 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.02 0.004 CID_290378 | ||
| 0.09 | 0.07 | 0.09 | Platelet activating factor beta antagonist | |||
| 0.054 | 0.034 | 0.054 | 5 Hydroxytryptamine 2 agonist | |||
| 0.035 | 0.015 | 0.035 | Diacylglycerol O-acyltransferase 1 inhibitor | |||
| 0.057 | 0.037 | 0.057 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.059 | 0.039 | 0.059 | EphB4 antagonist | |||
| 0.026 | 0.006 | 0.033 | Cyclin T1 inhibitor | 0.033 0.005 CID_290378 | CID_290378 | |
| 0.052 | 0.032 | 0.052 | Adenosine A2b receptor antagonist | |||
| 0.123 | 0.104 | 0.123 | Acetylcholine M1 receptor antagonist | |||
| 0.052 | 0.032 | 0.052 | Alpha 1b adrenoreceptor agonist | |||
| 0.024 | 0.005 | 0.024 | Complement factor D inhibitor | 0.018 0.012 CID_290378 | ||
| 0.032 | 0.013 | 0.032 | Purinergic P2Y15 antagonist | |||
| 0.056 | 0.037 | 0.056 | Bromodomain-containing protein 4 inhibitor | |||
| 0.035 | 0.017 | 0.035 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.062 | 0.044 | 0.062 | Protease activated receptor antagonist | |||
| 0.034 | 0.016 | 0.099 | Purinergic P2Y14 antagonist | 0.099 0.004 CID_290378 | CID_290378 | |
| 0.103 | 0.085 | 0.103 | Microtubule formation inhibitor | |||
| 0.028 | 0.011 | 0.028 | Adenosine kinase inhibitor | |||
| 0.074 | 0.056 | 0.074 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.074 0.057 CID_290378 | ||
| 0.054 | 0.036 | 0.054 | Heparanase inhibitor | |||
| 0.035 | 0.018 | 0.035 | Potassium channel small-conductance Ca-activated activator | |||
| 0.051 | 0.034 | 0.673 | Phosphodiesterase 4A inhibitor | 0.673 0.002 CID_290378 | CID_290378 | |
| 0.07 | 0.054 | 0.07 | Glycine receptor agonist | |||
| 0.031 | 0.015 | 0.031 | 5 Hydroxytryptamine 6 agonist | |||
| 0.029 | 0.013 | 0.029 | Thymidine phosphorylase inhibitor | |||
| 0.073 | 0.057 | 0.073 | Na+ K+ transporting ATPase inhibitor | |||
| 0.106 | 0.09 | 0.106 | Nav1.3 sodium channel blocker | |||
| 0.042 | 0.026 | 0.042 | Cyclin D3 inhibitor | |||
| 0.02 | 0.004 | 0.02 | Imidazoline I2 receptor antagonist | |||
| 0.042 | 0.027 | 0.042 | Kainate receptor agonist | 0.039 0.034 CID_290378 | ||
| 0.03 | 0.015 | 0.03 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.056 | 0.04 | 0.056 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.037 | 0.021 | 0.037 | Glucose-dependent insulinotropic receptor agonist | |||
| 0.057 | 0.042 | 0.057 | CDK9/cyclin T1 inhibitor | 0.057 0.043 CID_290378 | ||
| 0.167 | 0.152 | 0.167 | Calpain inhibitor | |||
| 0.031 | 0.016 | 0.031 | CDK4/cyclin D3 inhibitor | |||
| 0.066 | 0.052 | 0.066 | CDK1/cyclin B1 inhibitor | |||
| 0.04 | 0.025 | 0.04 | G protein-coupled receptor agonist | |||
| 0.016 | 0.002 | 0.016 | CC chemokine 6 receptor agonist | 0.007 0.004 CID_290378 | ||
| 0.044 | 0.03 | 0.044 | Phosphodiesterase 3B inhibitor | |||
| 0.074 | 0.06 | 0.074 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.018 | 0.005 | 0.018 | Egl nine homolog 3 inhibitor | |||
| 0.054 | 0.04 | 0.054 | Dihydroorotate oxidase inhibitor | |||
| 0.031 | 0.017 | 0.031 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.038 | 0.025 | 0.038 | Glutamate (mGluR8) agonist | 0.036 0.032 CID_290378 | ||
| 0.022 | 0.01 | 0.022 | Toll-Like receptor 8 agonist | |||
| 0.183 | 0.171 | 0.183 | 12-Lipoxygenase inhibitor | |||
| 0.148 | 0.136 | 0.148 | Insulin sensitizer | |||
| 0.032 | 0.02 | 0.032 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.057 | 0.046 | 0.057 | Ryanodine receptor antagonist | |||
| 0.024 | 0.012 | 0.024 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.041 | 0.03 | 0.064 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.064 0.005 CID_290378 | CID_290378 | |
| 0.028 | 0.016 | 0.028 | Integrin alpha2beta1 antagonist | |||
| 0.017 | 0.006 | 0.017 | 5 Lipoxygenase activating protein inhibitor | |||
| 0.075 | 0.064 | 0.119 | Carbonic anhydrase VI inhibitor | 0.119 0.03 CID_290378 | CID_290378 | |
| 0.037 | 0.026 | 0.037 | Delayed rectifier potassium channel blocker | |||
| 0.051 | 0.039 | 0.051 | Histamine agonist | |||
| 0.065 | 0.054 | 0.065 | MDM2 inhibitor | |||
| 0.044 | 0.033 | 0.044 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.018 | 0.007 | 0.018 | CDK2/cyclin A3 inhibitor | |||
| 0.016 | 0.005 | 0.016 | Cyclin D2 inhibitor | |||
| 0.163 | 0.152 | 0.163 | Spasmolytic | |||
| 0.043 | 0.032 | 0.043 | AICAR transformylase inhibitor | |||
| 0.018 | 0.007 | 0.018 | Egl nine homolog 1 inhibitor | |||
| 0.037 | 0.026 | 0.037 | Integrin alpha2 antagonist | |||
| 0.039 | 0.028 | 0.053 | Histone deacetylase 9 inhibitor | 0.053 0.014 CID_290378 | CID_290378 | |
| 0.035 | 0.024 | 0.035 | Phosphoglycerate kinase inhibitor | |||
| 0.043 | 0.032 | 0.043 | Dihydrofolate reductase inhibitor | |||
| 0.052 | 0.042 | 0.09 | Carbonic anhydrase VB inhibitor | 0.09 0.019 CID_290378 | CID_290378 | |
| 0.027 | 0.017 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.029 | 0.02 | 0.029 | Liver X receptor beta antagonist | |||
| 0.034 | 0.025 | 0.043 | Angiotensin II receptor antagonist | 0.043 0.011 CID_290378 | CID_290378 | |
| 0.028 | 0.019 | 0.028 | Uridine phosphorylase inhibitor | 0.024 0.023 CID_290378 | ||
| 0.017 | 0.008 | 0.017 | CXC chemokine 4 receptor agonist | |||
| 0.019 | 0.01 | 0.019 | Nicotinic acid receptor 1 antagonist | |||
| 0.028 | 0.019 | 0.028 | Protocollagen prolyl hydroxylase inhibitor | |||
| 0.024 | 0.015 | 0.024 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.033 | 0.025 | 0.033 | Fumarate hydratase inhibitor | |||
| 0.176 | 0.168 | 0.204 | Lipoxygenase inhibitor | 0.204 0.136 CID_290378 | CID_290378 | |
| 0.058 | 0.05 | 0.058 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.091 | 0.083 | 0.091 | AMP-activated protein kinase stimulant | |||
| 0.036 | 0.028 | 0.036 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.057 | 0.049 | 0.057 | CDK1/cyclin B inhibitor | |||
| 0.078 | 0.07 | 0.078 | Insulin growth factor antagonist | |||
| 0.036 | 0.029 | 0.036 | Farnesoid X receptor agonist | |||
| 0.039 | 0.032 | 0.039 | Liver X receptor alpha agonist | |||
| 0.017 | 0.011 | 0.022 | CC chemokine 9 receptor antagonist | 0.022 0.005 CID_290378 | CID_290378 | |
| 0.021 | 0.014 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.025 | 0.019 | 0.025 | Acid ceramidase inhibitor | |||
| 0.026 | 0.02 | 0.026 | Nicotinic acid receptor 2 antagonist | |||
| 0.026 | 0.02 | 0.026 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.029 | 0.024 | 0.029 | Epoxide hydrolase 1 inhibitor | |||
| 0.052 | 0.047 | 0.052 | Alpha 1 adrenoreceptor agonist | |||
| 0.051 | 0.045 | 0.051 | Bruton tyrosine kinase inhibitor | |||
| 0.042 | 0.038 | 0.042 | Adenylate cyclase 1 inhibitor | |||
| 0.063 | 0.059 | 0.063 | Prostaglandin-E synthase inhibitor | |||
| 0.033 | 0.029 | 0.033 | Nicotinic acid receptor agonist | |||
| 0.059 | 0.055 | 0.059 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.033 | 0.03 | 0.033 | Histone deacetylase 7 inhibitor | |||
| 0.073 | 0.07 | 0.073 | Calcium antagonist | |||
| 0.053 | 0.049 | 0.053 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.074 | 0.071 | 0.074 | Insulin like growth factor 1 antagonist | |||
| 0.163 | 0.16 | 0.163 | Cardiotonic | |||
| 0.052 | 0.049 | 0.052 | CXC chemokine 4 receptor antagonist | |||
| 0.054 | 0.051 | 0.054 | Heat shock protein 90 beta antagonist | |||
| 0.04 | 0.037 | 0.04 | Sphingosine 1-phosphate receptor agonist | |||
| 0.037 | 0.035 | 0.037 | Thymidine kinase inhibitor | |||
| 0.046 | 0.044 | 0.176 | Factor IXa inhibitor | 0.176 0.003 CID_290378 | CID_290378 | |
| 0.022 | 0.02 | 0.022 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.023 | 0.021 | 0.023 | Glutamate (mGluR1) agonist | |||
| 0.058 | 0.057 | 0.058 | Histone deacetylase inhibitor | |||
| 0.072 | 0.071 | 0.072 | Glycine receptor antagonist | |||
| 0.03 | 0.028 | 0.03 | Liver X receptor beta agonist | |||
| 0.055 | 0.054 | 0.055 | Transcription factor AP-1 inhibitor | |||
| 0.05 | 0.049 | 0.05 | Phosphodiesterase II inhibitor | |||
| 0.06 | 0.059 | 0.06 | Calcium channel P-type blocker | |||
| 0.011 | 0.013 | 0.035 | Human herpes virus 5 capsid protein P40 inhibitor | 0.035 0.003 CID_290378 | CID_290378 | |
| 0.034 | 0.04 | 0.04 | AMPA 4 receptor antagonist | 0.04 0.027 CID_290378 | CID_290378 | |
| 0.058 | 0.064 | 0.085 | Carbonic anhydrase VA inhibitor | 0.085 0.033 CID_290378 | CID_290378 | |
| 0.091 | 0.099 | 0.1 | Alkylator | 0.1 0.089 CID_290378 | CID_290378 | |
| 0.008 | 0.019 | 0.018 | Angiotensin AT1B receptor antagonist | 0.018 0.007 CID_290378 | CID_290378 | |
| 0.029 | 0.041 | 0.036 | Factor XIIIa inhibitor | 0.036 0.027 CID_290378 | CID_290378 | |
| 0.014 | 0.027 | 0.025 | CXC chemokine 5 receptor antagonist | 0.025 0.005 CID_290378 | CID_290378 | |
| 0.035 | 0.051 | 0.041 | VCAM-1 antagonist | 0.041 0.023 CID_290378 | CID_290378 | |
| 0.07 | 0.088 | 0.083 | Histamine H2 receptor antagonist | 0.083 0.058 CID_290378 | CID_290378 | |
| 0.034 | 0.052 | 0.041 | VCAM antagonist | 0.041 0.023 CID_290378 | CID_290378 | |
| 0.057 | 0.074 | 0.099 | Carbonic anhydrase XIII inhibitor | 0.099 0.038 CID_290378 | CID_290378 | |
| 0.049 | 0.071 | 0.079 | Carbonic anhydrase V inhibitor | 0.079 0.036 CID_290378 | CID_290378 | |
| 0.198 | 0.231 | 0.326 | Antibacterial | 0.326 0.117 CID_290378 | CID_290378 | |
| 0.051 | 0.096 | 0.084 | Histamine H1 receptor antagonist | 0.084 0.054 CID_290378 | CID_290378 | |
| 0.024 | 0.07 | 0.318 | Factor XIa inhibitor | 0.318 0.002 CID_290378 | CID_290378 | |
| 0.019 | 0.065 | 0.057 | Catechol O-methyltransferase inhibitor | 0.057 0.007 CID_290378 | CID_290378 | |
| 0.172 | 0.219 | 0.22 | Calpain 2 inhibitor | 0.22 0.171 CID_290378 | CID_290378 | |
| 0.058 | 0.106 | 0.087 | Potassium channel (Ca-activated) activator | 0.087 0.067 CID_290378 | CID_290378 | |
| 0.02 | 0.075 | 0.041 | Factor Xa inhibitor | 0.041 0.036 CID_290378 | CID_290378 | |
| 0.052 | 0.122 | 0.096 | NMDA receptor antagonist | 0.096 0.049 CID_290378 | CID_290378 | |
| 0.125 | 0.198 | 0.702 | Vasodilator | 0.702 0.004 CID_290378 | CID_290378 | |
| 0.089 | 0.167 | 0.251 | Neurotrophic factor | 0.251 0.012 CID_290378 | CID_290378 | |
| 0.015 | 0.096 | 0.035 | CC chemokine 8 receptor antagonist | 0.035 0.005 CID_290378 | CID_290378 | |
| 0.027 | 0.115 | 0.152 | Farnesyltransferase inhibitor | 0.152 0.005 CID_290378 | CID_290378 | |
| 0.016 | 0.104 | 0.266 | Factor XI inhibitor | 0.266 0.003 CID_290378 | CID_290378 | |
| 0.051 | 0.141 | 0.149 | 5-Lipoxygenase inhibitor | 0.149 0.038 CID_290378 | CID_290378 | |
| 0.007 | 0.154 | 0.126 | Plasma kallikrein inhibitor | 0.126 0.004 CID_290378 | CID_290378 | |
| 0.018 | 0.165 | 0.186 | Kallikrein inhibitor | 0.186 0.005 CID_290378 | CID_290378 | |
| 0.01 | 0.198 | 0.044 | Oxytocin antagonist | 0.044 0.021 CID_290378 | CID_290378 | |
| 0.004 | 0.203 | 0.026 | Growth hormone releasing factor antagonist | 0.026 0.015 CID_290378 | CID_290378 | |
| 0.073 | 0.281 | 0.19 | Insulin secretagoues | 0.19 0.041 CID_290378 | CID_290378 | |
| 0.043 | 0.254 | 0.108 | DNA directed RNA polymerase inhibitor | 0.108 0.048 CID_290378 | CID_290378 | |
| 0.015 | 0.257 | 0.066 | Dopamine agonist | 0.066 0.047 CID_290378 | CID_290378 | |
| 0.021 | 0.281 | 0.074 | CDC25A inhibitor | 0.074 0.051 CID_290378 | CID_290378 | |
| 0.008 | 0.289 | 0.391 | Dopamine D4 agonist | 0.391 0.004 CID_290378 | CID_290378 | |
| 0.028 | 0.343 | 0.088 | Viral attachment inhibitor | 0.088 0.036 CID_290378 | CID_290378 | |
| 0.037 | 0.376 | 0.354 | Anticoagulant | 0.354 0.021 CID_290378 | CID_290378 | |
| 0.07 | 0.555 | 0.205 | Apoptosis antagonist | 0.205 0.172 CID_290378 | CID_290378 | |
| 0.009 | 0.524 | 0.094 | Chemokine receptor antagonist | 0.094 0.069 CID_290378 | CID_290378 | |
| 0.021 | 0.557 | 0.161 | Free radical scavenger | 0.161 0.132 CID_290378 | CID_290378 | |
| 0.007 | 0.568 | 0.096 | CC chemokine receptor antagonist | 0.096 0.038 CID_290378 | CID_290378 | |
| 0.007 | 0.57 | 0.049 | CC chemokine 5 receptor antagonist | 0.049 0.038 CID_290378 | CID_290378 | |
| 0.014 | 0.578 | 0.2 | Lipid peroxidase inhibitor | 0.2 0.042 CID_290378 | CID_290378 | |
| 0.017 | 0.657 | 0.167 | Antioxidant | 0.167 0.146 CID_290378 | CID_290378 | |
| 0.005 | 0.681 | 0.24 | Protein-tyrosine phosphatase 1B inhibitor | 0.24 0.018 CID_290378 | CID_290378 | |
| 0.005 | 0.731 | 0.246 | Protein-tyrosine phosphatase inhibitor | 0.246 0.032 CID_290378 | CID_290378 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |